S. 274 · 112th Congress
Medication Therapy Management Empowerment Act of 2011
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 112th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
HaganSponsor17 cosponsors · 14 D, 3 R
D
Brown
AF
D
Franken
TJ
D
Johnson
RW
D
Wyden
AK
D
Klobuchar
SW
D
Whitehouse
BC
D
Cardin
DI
D
Inouye
CC
D
Coons
BM
D
Mikulski
CS
D
Schumer
MB
D
Begich
DA
D
Akaka
KG
D
Gillibrand
OS
R
Snowe
TC
R
Cochran
SB
R
Brown3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Medication Therapy Management Empowerment Act of 2011 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA), as amended by the Patient Protection and Affordable Care Act, to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy…
What it does: CRS summary · Introduced in Senate · Feb 3, 2011
Medication Therapy Management Empowerment Act of 2011 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA), as amended by the Patient Protection and Affordable Care Act, to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management (MTM) services.
Requires a Prescription Drug Plan (PDP) sponsor to establish a process, subject to approval by the Secretary of Health and Human Services (HHS), for identifying individuals who are not targeted beneficiaries, are not otherwise offered MTM services, and whom a pharmacist or other qualified provider determines may benefit from MTM services. Requires any such individual to be treated as a targeted beneficiary.
Requires any MTM program to offer both comprehensive and targeted medication reviews to individuals dually eligible for both Medicare and Medicaid (under SSA title XIX), regardless of whether they are MTM-targeted beneficiaries.
Requires a PDP sponsor to offer any willing pharmacy in its network and any other qualified health care provider the opportunity to provide MTM services.
Requires the PDP sponsor to reimburse pharmacists and other qualified health care providers furnishing MTM services based on the resources used and the time required to provide such services.
Directs the Secretary of HHS to: (1) establish measures and standards for data collection by PDP sponsors to evaluate performance of pharmacies and other entities in furnishing MTM services; and (2) support the continued development and refinement of performance measures.
Provides pharmacies and other entities that furnish MTM services with additional incentive payments based on their performance in meeting quality measures established under this Act.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Medication Therapy Management Empowerment Act of 2011
Latest action (Feb 3, 2011): Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: Senate · Introduced: Feb 3, 2011
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.